Women's tennis star Iga Swiatek accepted a one-month suspension from the International Tennis Integrity Agency, where she reflected on the "worst experience of my life."

The world number two and five-times Grand Slam champion has tested positive for banned substance trimetazidine.

Iga Swiatek failed a doping test in August for a banned heart medication. But authorities said it appeared to be an honest mistake exhibiting "no significant fault or negligence," issuing a fairly minor punishment.

Five-time Grand Slam champion Iga Swiatek accepted a one-month suspension after testing positive for the banned substance trimetazidine, a heart medication known as TMZ, the International Tennis Integrity Agency announced Thursday. Swiatek failed an out-of-competition drug test in August, and the ITIA accepted her explanation that the result was unintentional and caused by the contamination of a nonprescription medication, melatonin, that Swiatek was taking for issues with jet lag and sleeping.It was determined her level of fault was “at the lowest end of the range for no significant fault or negligence,” the ITIA said.“This experience, the most difficult in my life so far, taught me a lot,” Swiatek, a 23-year-old from Poland, said in a video she posted on social media.“The whole thing will definitely stay with me for the rest of my life. It took a lot to return to training after the situation nearly broke my heart, so there were many tears and lots of sleepless nights,” Swiatek said, speaking in Polish with…

World No 2 failed out-of-competition test for taking prohibited substance

World No. 2 women's singles player Iga Swiatek accepted a one-match ban after a failed doping test in August 2024. The five-time Grand Slam champion tested positive for a prohibited substance -- trimetazidine.

The International Tennis Integrity Agency says five-time Grand Slam champion Iga Swiatek has accepted a one-month suspension after testing positive for the banned substance trimetazidine.